APA (7th ed.) Citation

Ducray, F., Ramirez, C., Robert, M., Fontanilles, M., Bronnimann, C., Chinot, O., . . . Lemarchand, C. (2023). A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension vs. Temozolomide Capsules. Pharmaceutics, 15(12), 2664. https://doi.org/10.3390/pharmaceutics15122664

Chicago Style (17th ed.) Citation

Ducray, François, et al. "A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension Vs. Temozolomide Capsules." Pharmaceutics 15, no. 12 (2023): 2664. https://doi.org/10.3390/pharmaceutics15122664.

MLA (9th ed.) Citation

Ducray, François, et al. "A Multicenter Randomized Bioequivalence Study of a Novel Ready-to-Use Temozolomide Oral Suspension Vs. Temozolomide Capsules." Pharmaceutics, vol. 15, no. 12, 2023, p. 2664, https://doi.org/10.3390/pharmaceutics15122664.